# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Top mid-cap performers: Avidity Biosciences, Iris Energy, Hims & Hers Health, John Wiley & Sons, Element Solutions, Cle...
Truist Securities analyst Tobey Sommer reiterates Korn Ferry (NYSE:KFY) with a Buy and raises the price target from $74 to $78.
Baird analyst Mark Marcon maintains Korn Ferry (NYSE:KFY) with a Outperform and raises the price target from $72 to $79.
Korn Ferry reports Q4 FY24 results, with revenue beating expectations and increased dividend. Stock up over 6%.
Korn Ferry (NYSE:KFY) reported quarterly earnings of $1.26 per share which beat the analyst consensus estimate of $1.12 by 12.5...